Revvity, Inc. (RVTY)
NYSE: RVTY · Real-Time Price · USD
96.95
+1.57 (1.65%)
May 22, 2026, 4:00 PM EDT - Market closed
Revvity Employees
Revvity had 11,000 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
11,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$263,855
Profits / Employee
$21,789
Market Cap
10.82B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 11,000 | 0 | - |
| Dec 29, 2024 | 11,000 | -500 | -4.35% |
| Dec 31, 2023 | 11,500 | -5,200 | -31.14% |
| Dec 31, 2022 | 16,700 | 0 | - |
| Dec 31, 2021 | 16,700 | 2,700 | 19.29% |
| Dec 31, 2020 | 14,000 | 1,000 | 7.69% |
| Dec 31, 2019 | 13,000 | 500 | 4.00% |
| Dec 31, 2018 | 12,500 | 1,500 | 13.64% |
| Dec 31, 2017 | 11,000 | 3,000 | 37.50% |
| Dec 31, 2016 | 8,000 | 0 | - |
| Dec 31, 2015 | 8,000 | 300 | 3.90% |
| Dec 31, 2014 | 7,700 | 100 | 1.32% |
| Dec 31, 2013 | 7,600 | 100 | 1.33% |
| Dec 31, 2012 | 7,500 | 300 | 4.17% |
| Dec 31, 2011 | 7,200 | 1,000 | 16.13% |
| Dec 31, 2010 | 6,200 | -2,000 | -24.39% |
| Dec 31, 2009 | 8,200 | 300 | 3.80% |
| Dec 31, 2008 | 7,900 | -800 | -9.20% |
| Dec 31, 2007 | 8,700 | 200 | 2.35% |
| Dec 31, 2006 | 8,500 | 500 | 6.25% |
| Dec 31, 2005 | 8,000 | -2,000 | -20.00% |
| Dec 31, 2004 | 10,000 | 0 | - |
| Dec 31, 2003 | 10,000 | -700 | -6.54% |
| Dec 31, 2002 | 10,700 | -100 | -0.93% |
| Dec 31, 2001 | 10,800 | -1,700 | -13.60% |
| Dec 31, 2000 | 12,500 | 500 | 4.17% |
| Dec 31, 1999 | 12,000 | -1,000 | -7.69% |
| Dec 31, 1998 | 13,000 | -1,000 | -7.14% |
| Dec 31, 1997 | 14,000 | -1,000 | -6.67% |
| Dec 31, 1996 | 15,000 | 0 | - |
| Dec 31, 1995 | 15,000 | -10,000 | -40.00% |
| Dec 31, 1994 | 25,000 | -7,000 | -21.88% |
| Dec 31, 1993 | 32,000 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Labcorp Holdings | 71,000 |
| Quest Diagnostics | 57,000 |
| ICON Public Limited Company | 41,900 |
| Charles River Laboratories International | 19,700 |
| Mettler-Toledo International | 18,100 |
| Illumina | 10,080 |
| RadNet | 9,276 |
| Medpace Holdings | 6,200 |
RVTY News
- 11 days ago - Revvity Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 11 days ago - Revvity Receives FDA Clearance for Total Testosterone Assay Enabling Comprehensive Automated Testosterone Testing Solution - Business Wire
- 17 days ago - Revvity price target raised to $105 from $95 at Barclays - TheFly
- 18 days ago - Revvity price target lowered to $117 from $125 at Baird - TheFly
- 18 days ago - Revvity price target lowered to $100 from $110 at Stifel - TheFly
- 18 days ago - Revvity price target lowered to $90 from $96 at JPMorgan - TheFly
- 18 days ago - Revvity price target raised to $120 from $115 at TD Cowen - TheFly
- 19 days ago - Revvity Earnings Call Transcript: Q1 2026 - Transcripts